| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-14 |
| filingDate |
2015-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2018-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2016151637-A |
| titleOfInvention |
A NEW POLYMORPHIC FORM OF N- [2- (6-fluoro-1H-indol-3-yl) ethyl] -3 (2,2,3,3-tetrafluoropropoxy) benzylamine hydrochloride for the treatment of alzheimer's disease |
| priorityDate |
2014-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |